Oculus Innovative Sciences to sell stock-and-warrant units to public

Bookrunner Dawson James Securities may participate in deal as investor

By Devika Patel

Knoxville, Tenn., March 17 – Oculus Innovative Sciences, Inc. will sell units in a public offering, according to a prospectus supplement filed Thursday with the Securities and Exchange Commission.

The units will each consist of one common share and one-quarter of a three-year warrant.

Dawson James Securities, Inc., the bookrunner, may participate.

Settlement is expected March 23.

Proceeds will be used for working capital and general corporate purposes.

Oculus is a specialty pharmaceutical company based in Petaluma, Calif., that develops and markets solutions for the treatment of dermatological conditions and tissue care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.